Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

The synthetic cannabinoid WIN 55212-2 differentially modulates thigmotaxis but not spatial learning in adolescent and adult animals.

Acheson SK, Moore NL, Kuhn CM, Wilson WA, Swartzwelder HS.

Neurosci Lett. 2011 Jan 10;487(3):411-4. doi: 10.1016/j.neulet.2010.10.067. Epub 2010 Nov 3.

2.

Effects of delta9-THC and WIN-55,212-2 on place preference in the water maze in rats.

Robinson L, Hinder L, Pertwee RG, Riedel G.

Psychopharmacology (Berl). 2003 Feb;166(1):40-50. Epub 2002 Dec 14.

PMID:
12488948
3.

Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.

Wegener N, Koch M.

Brain Res. 2009 Feb 9;1253:81-91. doi: 10.1016/j.brainres.2008.11.081. Epub 2008 Dec 3.

PMID:
19094973
4.

Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats.

Wegener N, Kuhnert S, Thüns A, Roese R, Koch M.

Psychopharmacology (Berl). 2008 Jun;198(3):375-85. doi: 10.1007/s00213-008-1148-1. Epub 2008 Apr 30.

PMID:
18446326
6.

Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain.

Moranta D, Esteban S, García-Sevilla JA.

Naunyn Schmiedebergs Arch Pharmacol. 2004 May;369(5):516-24. Epub 2004 Apr 3.

PMID:
15064921
8.

Chronic exposure to WIN55,212-2 affects more potently spatial learning and memory in adolescents than in adult rats via a negative action on dorsal hippocampal neurogenesis.

Abboussi O, Tazi A, Paizanis E, El Ganouni S.

Pharmacol Biochem Behav. 2014 May;120:95-102. doi: 10.1016/j.pbb.2014.02.014. Epub 2014 Feb 26.

PMID:
24582851
9.

The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.

Pamplona FA, Prediger RD, Pandolfo P, Takahashi RN.

Psychopharmacology (Berl). 2006 Nov;188(4):641-9. Epub 2006 Sep 1.

PMID:
16947018
10.

Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation.

Marchalant Y, Rosi S, Wenk GL.

Neuroscience. 2007 Feb 23;144(4):1516-22. Epub 2006 Dec 18.

11.

Behavioural and dopaminergic alterations induced by a low dose of WIN 55,212-2 in a conditioned place preference procedure.

Polissidis A, Chouliara O, Galanopoulos A, Marselos M, Papadopoulou-Daifoti Z, Antoniou K.

Life Sci. 2009 Jul 31;85(5-6):248-54. doi: 10.1016/j.lfs.2009.05.015. Epub 2009 Jun 7.

PMID:
19508876
12.

Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.

Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M.

Eur J Pharmacol. 2007 Nov 14;573(1-3):11-9. Epub 2007 Jul 4.

PMID:
17644084
13.

Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.

Zhang CQ, Wu HJ, Wang SY, Yin S, Lu XJ, Miao Y, Wang XH, Yang XL, Wang Z.

Neuroscience. 2013 Dec 3;253:183-93. doi: 10.1016/j.neuroscience.2013.08.056. Epub 2013 Sep 5.

PMID:
24013008
14.
15.

Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.

Klugmann M, Klippenstein V, Leweke FM, Spanagel R, Schneider M.

Int J Neuropsychopharmacol. 2011 May;14(4):505-17. doi: 10.1017/S1461145710001562. Epub 2011 Jan 7. Erratum in: Int J Neuropsychopharmacol. 2011 May;14(4):519.

PMID:
21211107
16.

Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats.

Drews E, Schneider M, Koch M.

Pharmacol Biochem Behav. 2005 Jan;80(1):145-50. Epub 2004 Dec 30.

PMID:
15652390
17.

Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats.

Schneider M, Schömig E, Leweke FM.

Addict Biol. 2008 Sep;13(3-4):345-57. doi: 10.1111/j.1369-1600.2008.00117.x.

PMID:
18782382
18.

WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction.

Robinson L, Goonawardena AV, Pertwee R, Hampson RE, Platt B, Riedel G.

Behav Brain Res. 2010 Apr 2;208(2):584-92. doi: 10.1016/j.bbr.2010.01.004. Epub 2010 Jan 14.

19.

Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2.

Nallapaneni A, Liu J, Karanth S, Pope C.

Toxicology. 2006 Oct 3;227(1-2):173-83. Epub 2006 Aug 5.

PMID:
16956707
20.

The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.

Koch M, Kreutz S, Böttger C, Grabiec U, Ghadban C, Korf HW, Dehghani F.

Hippocampus. 2011 May;21(5):554-64. doi: 10.1002/hipo.20772.

PMID:
20135626
Items per page

Supplemental Content

Write to the Help Desk